Dr. Agarwal’s Health Care Limited announced strong financial results for the second quarter and first half of FY27. Revenue from operations grew by 31.4% year-on-year to INR 655 crores in Q2 FY27. The company also saw a significant increase in EBITDA and PAT, with plans to expand its network by adding 65 new facilities this year. This expansion includes 55 new surgical centers, reflecting a robust growth strategy.
Dr. Agarwal’s Health Care Limited Announces Strong Q2 and H1 FY27 Results
Dr. Agarwal’s Health Care Limited has reported a robust performance for the second quarter and the first half of the fiscal year 2027 (FY27). The company highlighted a significant year-on-year increase in revenue and profitability, underpinned by its ongoing network expansion and clinical excellence initiatives.
Financial Highlights
Q2 FY27 Performance
- Total income for Q2 FY27 stood at INR 665 crores, an increase of 31.3% year-on-year.
- Revenue from operations rose by 31.4% year-on-year to INR 655 crores.
- Ind AS EBITDA for the quarter was INR 186 crores, reflecting a 28.8% year-on-year growth, with margins stable around 28%.
- PAT grew by 55.8% year-on-year to INR 57 crores, with PAT margin expanding by 134 basis points to 8.5%.
H1 FY27 Performance
- The company reported a total income of INR 1,286 crores for the first half of FY27, up 27.6% year-on-year.
- Revenue from operations increased by 28.7% to INR 1,269 crores.
- Ind AS EBITDA for H1 FY27 grew 27% to INR 362 crores, with margins stable at 28.2%.
- PAT grew by 50.1% year-on-year to INR 112 crores, with PAT margin expanding to 8.7%.
Network Expansion and Operational Updates
Dr. Agarwal’s Health Care Limited continued its aggressive network expansion, adding 21 new facilities in Q2 FY27, comprising 19 Greenfield centers and 2 acquired facilities. For the first half of FY27, the company added a total of 39 facilities. The company has revised its guidance for facility additions to 65 new facilities for the full year, including 55 new surgical centers, up from the earlier guidance of 60 facilities (40 surgical centers).
The company’s focus on clinical excellence was highlighted by the launch of the world’s first Pinhole Pupilloplasty capable department in Chennai. Surgical volumes have shown strong growth, with cataract surgeries remaining the largest contributor and refractive surgeries seeing a significant increase.
Region-wise Performance
- The Southern region remains the largest market, contributing 62% of total group revenues, with a 24.6% year-on-year growth in H1.
- The West region contributed 15% of group revenues, delivering INR 195 crores in H1, up 30% year-on-year.
- The North region, a fast-growing market, contributed 9% of group revenues, reporting INR 115 crores in H1 FY27, up by 60% year-on-year. Expansion in Delhi-NCR has been a key focus.
- The East region saw revenue of INR 35 crores, up by 30% year-on-year.
The company reiterated its strategy of predominantly building through Greenfield expansion while remaining open to strategic bolt-on acquisitions that fit well within its expansion plans and offer the right multiples.
Outlook
Dr. Agarwal’s Health Care Limited expressed confidence in sustaining its growth momentum, driven by operational discipline, consistent execution, and strategic expansion. The company anticipates continued strong performance in the upcoming quarters.
Source: BSE
